QZQian Zhang

Qian Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qian Zhang has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association of composite dietary antioxidant index (CDAI) with all-cause mortality in adults with abdominal obesity

    by Qingmei Niu, Yatian Jia, Shuo Ding, Yuxiang Gao, Wenjing Li, Qian Zhang

    Abdominal obesity, defined by the pathological accumulation of visceral adipose tissue, is a key manifestation of metabolic syndrome and is associated with greater health risks than general obesity...

  • Efficacy and mechanism of flavonoids in improving dry eye disease: a systematic review of animal studies

    by Jie Lyu, Shi-Yu Jiao, Wen-Jing Li, Shuo Ding, Qian Zhang

    AIM: To systematically summarize the efficacy and safety of flavonoids in the treatment of dry eye disease (DED), and review their mechanisms of action, and provide a scientific foundation for clinical translation. METHODS: To retrieve papers published from the establishment of the database through May 12, 2025, eight databases were searched: the Chinese National Knowledge Infrastructure (CNKI), the China Biomedical Literature Database (CBM), the Wanfang Database, the China Science, Technology Journal Database, PubMed, the Cochrane Library, Embase, and the Web of Science. Two independent researchers conducted the literature selection and information extraction processes, utilizing the SYRCLE tool to assess the risk of bias. The results of eligible studies were subjected to narrative analysis. RESULTS: A total of 11 animal studies were included in this review, encompassing research conducted in China, the United States, Republic of Korea, and Japan. These studies involved six flavonoid-rich substances, such as Buddleja officinalis and purple corn extract (PCE), as well as four individual flavonoids including quercetin and daidzin, etc. The findings indicated that flavonoids have the potential to enhance tear secretion. Following interventions with quercetin eye drops and PCE administered at varying doses and time intervals, a significant increase in tear secretion was observed, which approached normal levels. Additionally, these interventions demonstrated a capacity to mitigate damage to the corneal epithelium. For instance, maqui berry extract (MBE) were found to improve corneal fluorescein staining scores while reducing damage to the corneal surface. Flavonoids significantly alleviate dry eye symptoms in animal models by enhancing tear secretion and mitigating corneal epithelial damage. The observed efficacy is attributed to a range of mechanisms, including anti-inflammatory, antioxidant, hormonal regulation, and anti-apoptotic effects. CONCLUSION: The consistent therapeutic outcomes noted in both mouse and rat models further underscore the translational potential of these compounds. Consequently, flavonoids are regarded as highly promising natural agents for ocular health. However, additional pharmacokinetic studies and clinical trials are necessary to confirm their efficacy and safety in human subjects with dry eye syndrome.

  • Open Access

    Multidisciplinary Formulation of a Walking Rehabilitation Nursing Protocol for Patients with Lower Extremity Arteriosclerosis Obliterans: A Delphi Study

    by Qingmei Niu, Qian Zhang, Ying Yu, Yatian Jia, Xinru Li, Yihua Zhang

    Objective: To develop a contextually tailored walking rehabilitation protocol for Chinese patients with lower extremity arteriosclerosis obliterans (ASO), providing evidence-based theoretical and practical guidance for clinical nursing. Background: Lower extremity ASO is a prevalent chronic vascular disease with rising incidence, high morbidity, and mortality. Exercise interventions effectively improve patients’ walking ability, and supervised walking programs are promising, yet standardized clinical guidelines remain lacking. Methods: An evidence-based protocol was developed via systematic review of domestic and international literature. A preliminary draft was refined through two rounds of Delphi consultations with 20 multidisciplinary experts (vascular surgery, nursing, rehabilitation). Statistical analysis of expert agreement finalized the standardized protocol. Results: Both rounds achieved a 100% response rate. Expert authority coefficients were 0.918 (Round 1) and 0.945 (Round 2). Coefficients of variation ranged 0.00– 0.21 (Round 1) and 0.00– 0.10 (Round 2). Kendall’s concordance coefficients were 0.131 and 0.339 (p< 0.05), indicating significant consensus. The final protocol includes 5 primary, 13 secondary, and 40 tertiary indicators. Conclusion: This Delphi-derived standardized walking rehabilitation protocol addresses gaps in current guidelines and provides an evidence-based foundation for standardized Lower extremity ASO interventions.

  • Open Access

    Association between AISI and mortality among individuals with abdominal obesity: A cohort study

    by Qingmei Niu, Junkang Zhao, Yatian Jia, Shuo Ding, Yuxiang Gao, Wenjing Li, Qian Zhang

    This study examines the association between the aggregate index of systemic inflammation (AISI) and mortality among individuals with abdominal obesity, aiming to provide a scientific basis for accurate identification of high-risk individuals and the implementation of early interventions. This study utilized data from the National Health and Nutrition Examination Survey (NHANES) 1999–2016 to include adults with abdominal obesity. The AISI was calculated as (neutrophil count × platelet count × monocyte count)/lymphocyte count. Participants were linked to the National Death Index to determine vital status, with mortality follow-up extending through December 31, 2019. The association between the AISI and mortality risk in individuals with abdominal obesity was examined through Kaplan–Meier survival analysis, weighted Cox proportional hazards regression, subgroup stratification, and restricted cubic spline modeling. This cohort study enrolled 15,839 adult participants with abdominal obesity. During a median follow-up of 119 months, 2223 deaths were recorded. Kaplan–Meier survival analysis showed that elevated levels of the AISI were significantly associated with reduced survival probability. After comprehensive adjustment for multiple potential confounders, multivariate Cox proportional hazards regression revealed a significant positive association between AISI levels and all-cause mortality risk in individuals with abdominal obesity. When AISI was treated as a continuous variable, each 1-unit increase was associated with a 1% higher risk of death (fully adjusted HR = 1.01, 95% CI: 1.01–1.01, P < .001). When dichotomized at the median, the high AISI group exhibited a 16% increased risk of mortality compared to the low AISI group (fully adjusted HR = 1.16, 95% CI: 1.04–1.30, P = .010). Restricted cubic spline analysis confirmed a statistically significant linear relationship ( P for overall < .001; P for nonlinearity = .192). Subgroup analyses indicated heterogeneity in this association across marital status subgroups (interaction P = .017). This study demonstrates that elevated AISI levels are associated with increased mortality risk among individuals with abdominal obesity. These findings underscore the value of AISI as a prognostic indicator for mortality in this at-risk population. The integration of AISI into clinical inflammatory assessment frameworks may facilitate the establishment of dynamic surveillance strategies for identifying and monitoring high-risk individuals.


  • Open Access

    Developing an Evaluation Framework Based on Entrustable Professional Activities for Advanced Practice Nurses in China

    by Shifan Han, Wenjing Dong, Xuan Duan, Feng Chen, Gege Cao, Ruifang Zhu, Qian Zhang

    Aim: To address conceptual ambiguity, unclear scope, and regulatory gaps hindering advanced practice nurse role implementation in China, this study developed an evaluation framework based on entrustable professional activities to facilitate the introduction, implementation, and development of the advanced practice nurses while guiding policy formulation, educational design, and credentialing. Background: Globally, advanced practice nurses are recognized for delivering high‐quality, safe, and cost‐effective care. Many countries have formalized this role, often marked by prescriptive authority. However, China lacks a clearly defined advanced practice nurse role and national evaluation standards, creating barriers to effective role integration. Methods: A scoping review identified international evaluation frameworks and their core components. A two‐round Delphi study with 27 experts established relevant entrustable professional activities, and structured consensus meetings refined the framework. Results: Delphi consensus was achieved on an entrustable professional activity framework consisting of 20 indicators across five domains: assisting in clinical assessment, diagnosis, and treatment; engaging in advanced nursing practice; communicating, consulting, coordinating, and collaborating; managing teaching and promoting research innovation; and preventing and managing chronic diseases. After two rounds of expert panel consultations, the final evaluation framework was established. Discussion: This framework clarifies advanced practice nurse roles and offers a coherent structure linking education, competencies, and clinical practice to promote practice‐ready development. Conclusion: This participatory framework provides an organized approach to evaluating advanced practice nurses’ competencies and role readiness, supporting safe and effective advanced practice. Implications for nursing: The framework supports competency‐based education, workplace assessment, and continuing professional development for advanced practice nurses. Implications for nursing policy: This evaluation framework offers a foundation for role legislation, credentialing, and evidence‐informed policy development in China.


  • Barriers and Facilitators to Implementation of Nurse Prescribing: A Qualitative Synthesis Based on the Consolidated Framework for Implementation Research

    by Qian Zhang, Gege Cao, Xuan Duan, Ruifang Zhu, Shifan Han

    Aims: To identify barriers and facilitators to nurse prescribing implementation through a synthesis of qualitative studies. Background: The roles of healthcare professionals are expanding in response to the growing demand for access to high‐quality healthcare services. Advanced practice nurses are a global trend, and nurse prescribing is a crucial feature of advanced practice nurses that can meet the needs of growing healthcare services. The development and promotion of nurse prescribing varies significantly across countries, and it is essential to identify the factors influencing the implementation of nurse prescribing. Methods: A systematic search of PubMed, Web of Science, Embase, Cochrane Library, CINAHL, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, Wan Fang and Weipu database was conducted to retrieve literature on barriers and facilitators related to the implementation of nurse prescribing. We searched records from inception to 29 March 2025. Two researchers independently performed literature screening, literature evaluation, data extraction and synthesis. Literature screening and data extraction adhered to the predefined inclusion and exclusion criteria. Literature quality was evaluated using the JBI Checklist for Qualitative Research. The results were synthesised using the thematic synthesis approach. Information was extracted using the Consolidated Framework for Implementation Research (CFIR) in a deductive way, and barriers and facilitators to the implementation were categorised based on the CFIR. Report rigour assessed via ENTREQ. Results: The synthesis of 14 included papers identified 18 thematic categories, yielding two key findings. The main barriers identified included failure to anticipate the cost of nurse prescribing, legal constraints, social pressures, poor organisational structure, insufficient prescribing education, lack of competence of nurses leading to psychological changes, opposition and lack of cooperation of team members, and insufficient planning of nurse prescribing. Facilitating factors included prescribing experience, resource and labor conservation, cost reduction, resources, nurses' prescribing training, leadership support, patients' needs, nursing professional development, nurses' competence, and team cooperation and support. Conclusion: Identifying barriers and facilitators to nurse prescribing is critical for informing policy‐making and clinical prescribing practices. The results offers practical guidance to develop strategic plans that enhance implementation and adoption of nurse prescribing. Relevance to Clinical Practice: Nurse prescribing improves patient access while mitigating healthcare strain. By streamlining medication delivery and optimising resource use in overburdened systems, this model strengthens patient‐centered care while allowing physician specialisation in complex cases. This workforce innovation enhances team‐based care and ensures continuity for vulnerable populations. Impact Statement: This paper identifies barriers and facilitators, offering policymakers, healthcare administrators, and educators actionable insights to enable nurse role expansion, reduce physician workload, and enhance outcomes through holistic care. Patient or Public Contribution: No patient or public contribution.


  • Open Access

    Network meta-analysis of the effects of different dietary patterns on patients with metabolic syndrome

    by Jie Lv, Shiyu Jiao, Wenjing Li, Shuo Ding, Li Ma, Qian Zhang

    Background: Dietary patterns play an important role in the management of metabolic syndrome (MetS). Previous meta-analyses have shown that the ketogenic diet, the Dietary Approaches to Stop Hypertension (DASH) diet, the vegetarian diet, the Mediterranean diet, the low-fat diet, and the low-carbohydrate diet are beneficial for patients with MetS, but there is still a lack of direct comparison of the intervention effects of the above six dietary patterns. Objective: This study aimed to explore the intervention efficacy of different dietary patterns on MetS and to evaluate and compare the corresponding effects. Methods: A comprehensive search was carried out in electronic databases such as Embase, Cochrane Library, PubMed, Web of Science, Scopus, CNKI, Wanfang, VIP, and CBM. The search covered studies published from the establishment of the databases up to 1 April 2025, with a focus on dietary patterns that can improve metabolic syndrome. A network meta-analysis was carried out using Stata 16.0 software. Results: Eventually, 26 randomized controlled trials were included, involving 2,255 patients. The results of the network meta-analysis showed that the DASH diet [MD = −5.72, 95% CI (−9.74, −1.71)] and the vegan diet [MD = −12.00, 95% CI (−18.96, −5.04)] were more effective in reducing the waist circumference of patients with MetS than the control diet group. In terms of lowering blood pressure, the DASH diet [MD = −5.99, 95% CI (−10.32, −1.65)] and the ketogenic diet [MD = −11.00, 95% CI (−17.56, −4.44)] were more effective in reducing systolic blood pressure in patients with MetS than the control diet group. The ketogenic diet [MD = −9.40, 95% CI (−13.98, −4.82)] was more effective in reducing diastolic blood pressure in patients with MetS than the control diet group ( p < 0.05). According to the ranking results, a vegan diet is the best choice in terms of reducing waist circumference and increasing high-density lipoprotein cholesterol levels. The ketogenic diet is highly effective in lowering blood pressure and triglyceride levels. The Mediterranean diet is highly effective in regulating fasting blood glucose. Conclusion: The current evidence indicates that the vegan diet, the ketogenic diet, and the Mediterranean diet might have more pronounced effects in ameliorating MetS. Further high-quality research is needed to validate these findings. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/ , identifier (CRD420251052075).


  • Open Access

    Propolis effects on blood sugar and lipid metabolism, inflammatory indicators, and oxidative stress in people with type 2 diabetes: a systematic review and meta-analysis

    by Yihua Zhang, Shuo Ding, Wenjing Li, Xiumei Wang, Jie Lv, Qingmei Niu, Qian Zhang

    Background: Type 2 Diabetes Mellitus (T2DM) poses a significant global health challenge. Propolis, a natural bioactive compound, is proposed to modulate glucose and lipid metabolism and exert anti-inflammatory effects. However, previous reviews have limited scope, and the effects of propolis on T2DM remain debated, particularly concerning lipid profiles, glycemic control, inflammation, and oxidative stress.Methods: A systematic search was conducted across Chinese National Knowledge Infrastructure (CNKI), VIP, SinoMed, Wanfang Data, PubMed, Cochrane Library, Embase, Scopus, and Web of Science, with the search time limit set from the establishment of the databases to 20 May 2025. Study quality was assessed using the Cochrane Risk of Bias Assessment Tool version 2 (ROB 2); evidence quality was evaluated via the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach; and meta-analysis was performed using RevMan 5.4.Results: In total, 12 randomized controlled trials (RCTs) with 731 participants were included in this study. Propolis supplementation significantly increased high-density lipoprotein cholesterol (HDL-C) levels (mean difference (MD) = 0.13, 95% CI 0.10–0.16, p < 0.00001), and reduced low-density lipoprotein cholesterol (LDL-C) (MD = −0.32, 95% CI: −0.56 to −0.08; p = 0.009) and triglyceride (TG) levels (MD = −0.15, 95% CI: −0.30 to −0.01; p = 0.04). It also improved glycemic control, lowering fasting blood sugar (FBS) (MD = −1.13, 95% CI: −2.00 to −0.27, p = 0.01), homeostasis model assessment of insulin resistance (HOMA-IR) (MD = −0.95, 95% CI: −1.36 to −0.55, p < 0.00001), and glycosylated hemoglobin (HbA1c) (MD = −0.44, 95% CI: −0.78 to −0.11, p = 0.01). Furthermore, propolis significantly reduced C-reactive protein (CRP) (MD = −2.68, 95% CI: −3.48 to −1.89, p < 0.00001). However, no significant effects were observed for total cholesterol (TC), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), superoxide dismutase (SOD), or malondialdehyde (MDA).Conclusion: Propolis may improve lipid and glucose profiles and reduce inflammation in T2DM. While current evidence does not confirm significant effects on oxidative stress markers, considering the limitations of existing clinical studies and positive basic research findings, its potential antioxidant effects require validation through high-quality RCTs.Systematic review resistration: This study was registered with PROSPERO (registration number: CRD42024577722) https://www.crd.york.ac.uk/PROSPERO/#loginpage.